Latest news
Mesoblast (ASX:MSB) Is Back in Focus After RYONCIL Revenue Reaches US$115 Million - KalkineKalkine · Thu, 30 Jul 2026 07:00:00 GMTMesoblast reports $115M Ryoncil revenue in firs... - PluangPluang · Thu, 30 Jul 2026 01:11:43 GMTMesoblast reports $115M revenue in first year p... - PluangPluang · Thu, 30 Jul 2026 01:11:42 GMTMesoblast (ASX:MSB) Completes Phase 3 Back-Pain Enrolment as Ryoncil Growth and Pipeline Expansion Shape Next Phase - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMT